Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization.
AUTOR(ES)
Roche, P A
RESUMO
Class II molecules of the major histocompatibility complex (MHC) bind peptides derived from protein antigens delivered into endocytic compartments and present these peptides to CD4+ T cells. The precursors to functional MHC class II molecules loaded with peptides are complexes of the invariant chain associated with class II alpha beta heterodimers. Targeting of newly synthesized MHC class II molecules to endosomes is mediated by the invariant chain, but the intracellular transport route is not known. This study demonstrates that in a human B-cell line a large population of MHC class II-invariant chain complexes reaches endosomes by rapid internalization from the cell surface. Quantitation of cell surface MHC class II-invariant chain complexes and of their surface half-life revealed that 3000 complexes internalized per minute into endosomes. This highly efficient endocytosis was mediated by the cytoplasmic tail of the invariant chain. After internalization, the invariant chain dissociated from the MHC class II-invariant chain complexes. This pathway may represent an important mechanism for loading class II molecules with immunogenic peptides from several endocytic compartments.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=47401Documentos Relacionados
- Stable surface expression of invariant chain prevents peptide presentation by HLA-DR.
- Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus.
- Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.
- Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding.
- Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens.